Coherence Catalyst: 67 Structural Lenses for Blind Spots That Current Frameworks Miss
The failure nobody caught In 2023, a major pharmaceutical company's clinical trial passed every regulatory checkpoint. The sponsor followed protocol. The CRO executed the study design. The sites enrolled patients correctly. The IRB approved the ethics. The regulators reviewed the data. Every node in the system performed its function defensibly....
Sep 111